Tomocube, Inc. (KOSDAQ:475960)

South Korea flag South Korea · Delayed Price · Currency is KRW
51,100
+1,150 (2.30%)
At close: Dec 29, 2025
251.93%
Market Cap680.74B
Revenue (ttm)7.23B
Net Income (ttm)-7.93B
Shares Out13.32M
EPS (ttm)-614.86
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume336,360
Average Volume568,050
Open51,000
Previous Close49,950
Day's Range49,550 - 52,900
52-Week Range13,490 - 63,900
Betan/a
RSI52.90
Earnings DateMar 20, 2026

About Tomocube

Tomocube, Inc. engages in the manufacture and sale of optical devices and medical equipment. Its holotomography (HT) products include HT-X1 for live-cell imaging and analysis; and HT-2H for 3D live cell imaging. The company also offers TomoAnalysis, a 3D image visualization and analysis software. In addition, it provides accessories, such as HT-ready 96 well plates; TomoDish that is designed to accommodate both adherent and suspension cells; TomoChamber, a stage-top incubator designed for long-term live cell imaging; TomoPlate, an active vibrat... [Read more]

Industry Laboratory Apparatus and Furniture
Founded 2015
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 475960
Full Company Profile

Financial Performance

In 2024, Tomocube's revenue was 5.94 billion, an increase of 58.48% compared to the previous year's 3.75 billion. Losses were -8.30 billion, -64.75% less than in 2023.

Financial Statements

News

There is no news available yet.